Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Ossium Health, Inc.
Children's Hospital Medical Center, Cincinnati
Center for International Blood and Marrow Transplant Research
Wake Forest University Health Sciences
Mayo Clinic
M.D. Anderson Cancer Center
Thomas Jefferson University
UNC Lineberger Comprehensive Cancer Center
University of Wisconsin, Madison
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Barbara Ann Karmanos Cancer Institute
University of Rochester
UNC Lineberger Comprehensive Cancer Center
University of Florida
Case Comprehensive Cancer Center
JaxBio Ltd
Instituto Nacional de Cancer, Brazil
Therapeutic Advances in Childhood Leukemia Consortium
University Hospital, Clermont-Ferrand
University of Liege